skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Development of pretreatment compounds against nerve-gas agents. Annual report (Final), 16 May 88-30 Sep 90

Technical Report ·
OSTI ID:5398934

The U. S. Army Medical Research and Development Command is interested in research directed toward the development of countermeasures to chemical warfare (CW) agents such as the nerve gas poison soman. Soman and other nerve gas poisons are extremely potent cholinesterase inhibitors. This inhibition leads to a buildup of excess acetylcholine resulting in over-stimulation of both the peripheral and central nervous system and can lead to death. Standard therapy for organophosphate nerve agent poisoning is based on co-administration of an anticholinergic agent such as atropine to antagonize the effects of accumulated acetylcholine and a cholinesterase reactivator such as 2-PAM to dephosphorylate the inhibited enzyme. However, since many problems remain in the treatment of organophosphate nerve agent poisoning, there is considerable interest and need to develop new pretreatment and treatment drugs, particularly for soman poisoning.

Research Organization:
Research Triangle Inst., Durham, NC (United States)
OSTI ID:
5398934
Report Number(s):
AD-A-233691/5/XAB; CNN: DAMD17-88-C-8115
Country of Publication:
United States
Language:
English